The Novel Evidenced Assessment of Tortuosity (NEAT) system is intuitive and works even with poor images, according to its creators, Konstantinos Balaskas and his colleagues at Manchester Royal Eye Hospital and five other centres in the United Kingdom.
Where does a visual impairment begin? Vision disorders can be influenced by a combination of genetic factors, environmental conditions, and lifestyle choices. When taking these into account, beginning with proper prenatal care is a good place to start.
A National Eye Institute (NEI) study found that telemedicine can effectively screen for retinopathy of prematurity (ROP) and could potentially ease the strain on hospitals with limited access to ophthalmologists.
The University of Utah’s John A. Moran Eye Center has published a research paper originating from the center examining the role of erythropoietin (EPO) signaling in retinopathy of prematurity (ROP) in the American Journal of Pathology.
Treating retinopathy of prematurity (ROP) has a great value in societal terms due to the potentially long lifespans ahead of these patients. However, a comparison of bevacizumab (Avastin, Genentech) and laser for treating ROP found that drug therapy was more cost effective than laser, even with extended follow-up periods, according to Michael J. Geske, MD.